Introduction {#section1-1533033819853262}
============

Osteosarcoma (OS) is the most frequent human primary malignant bone tumor, occurring frequently in children and adolescents. The 5-year survival rate for OS patients has been recorded at 55% to 80% after effective chemotherapy.^[@bibr1-1533033819853262],[@bibr2-1533033819853262]^ In addition, the analysis of previous studies showed that the 5-year survival rate of metastatic patients is still less than 20%.^[@bibr3-1533033819853262]^ Pulmonary metastasis is the main cause of death for the patients with extremities OS.^[@bibr4-1533033819853262]^ Therefore, identifying the molecular mechanisms of metastasis of OS is necessary for the development of operational the therapeutic strategies.

Aurora-B (AURKB), a serine/threonine kinase, ensures the proper execution and fidelity of mitosis. Aurora-B is a member of the chromosomal passenger complex, which has been involved in various mitotic processes, including chromosome--microtubule interactions, mitotic spindle assembly/checkpoint, sister chromatid cohesion.^[@bibr5-1533033819853262],[@bibr6-1533033819853262]^ Recent studies indicates that AURKB, an important antitumor target, is strongly associated with metastasis of numerous tumor types.^[@bibr7-1533033819853262],[@bibr8-1533033819853262]^ Our previous studies revealed that knockdown of AURKB suppressed OS cells migratory, proliferation and invasion *in vitro*.^[@bibr9-1533033819853262],[@bibr10-1533033819853262]^ However, whether AURKB takes a role in OS metastasis and what is the mechanism is not yet clear.

In the present study, we confirmed that AURKB promote malignant phenotype of OS cells in vitro. Furthermore, we analyzed proteome alterations in 143B cells of upregulated AURKB group (U) and negative group (C). For this purpose, we utilized label-free quantitative proteomics technology^[@bibr11-1533033819853262]^ to quantify/visualize the changes in proteins expression abundance and identify differentially expressed proteins (DEPs) in the 2 groups of 143B cells. We performed functional annotation and functional enrichment analyses. Finally, gene ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and protein--protein interaction (PPI) networks were constructed and analyzed. We sought to explore the potential genes and pathways related to AURKB in osteosarcoma and to improve the role of AURKB in osteosarcoma, so as to provide some new ideas for the study of osteosarcoma. The findings of this study are likely to play a momentous role in osteosarcoma genesis and may provide new biomarkers for the diagnosis and treatment of osteosarcoma.

Materials and Methods {#section2-1533033819853262}
=====================

Cell Culture {#section3-1533033819853262}
------------

The U2-OS and 143B cell lines were purchased from the Shanghai Cell Bank, Chinese Academy of Sciences (Shanghai, China). Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (both Gibco; Thermo Fisher Scientific, Inc, Waltham, Massachusetts) and were cultured at 37°C in 5% CO~2~.

Plasmids and Transfection {#section4-1533033819853262}
-------------------------

The Lentivirus-Vectors were compound by GENECHEM (Shanghai, China). Osteosarcoma cells (U2-OS and 143B) were transfected with Lentivirus-Vectors of Lentivirus-Vectors of downregulating AURKB (LV/ShAURKB), upregulating AURKB (LV/AURKB), negative Lentivirus-Vectors (NC-LV/AURKB and NC-LV/ShAURKB).

Western Blot Analysis {#section5-1533033819853262}
---------------------

Total protein from 143B cells and U2-OS cells were extracted using BBproExtraTM (BB-3101). And protein concentration was determined using the Bicinchoninic acid assay (BCA) (Applygen Technologies Inc. Beijing, China). Proteins were separated by 8% SDS-PAGE (10 µg/lane) and transferred to polyvinylidene fluoride membranes. After blocking with 5% nonfat milk (Solarbio Science & Technology Co, Ltd., Beijing, China) for 1 hour at room temperature, the membranes were incubated overnight with the following specific/primary antibodies: rabbit monoclonal AURKB (EP1009Y; 1:50 000; Abcam, Cambridge, Massachusetts), rabbit monoclonal PI3K (EPR18702; 1:1000; Abcam), rabbit monoclonal PI3K (Tyr458; 1:1000; Cell Signaling Technology Inc, Boston, USA), rabbit monoclonal AKT (EPR18405; 1:2000; Abcam), rabbit monoclonal AKT (phospho T308; ab38449; 1:1000; Abcam), rabbit monoclonal nuclear factor-Kappa B (NF-κB, E379; 1:50 000; Abcam), rabbit monoclonal PTK2 (EP695Y; 1:1000; Abcam), and monoclonal mouse β-actin (TA-09; 1:2000; ZSGB-BIO, Inc., Beijing, China) at 4°C. The membrane was washed 3 times with TBST. The membranes were then incubated with secondary antibody for 1 hour at room temperature. The expression of indicated proteins were visualized using an EasySee Western Blot kit (Transgen, Inc., Beijing, China). The intensity of bands was measured using ImageJ version 1.48 software (National Institutes of Health, Bethesda, Massachusetts).

RNA Isolation and Quantitative Polymerase Chain Reaction {#section6-1533033819853262}
--------------------------------------------------------

Trizol (Invitrogen) method was used to extract the total RNA from OS cells. The expression level of AURKB was evaluated by quantificational real time-PCR. And GAPDH was used as the endogenous reference genes. Primer sequences used to amplify the containing were as follows: AURKB sense 5-AGAAGGAGAACTCCTACCCCT-3′, AURKB antisense 5′-CGCGTTAAGATGTCGGGTG-3′; GAPDH sense 5′-CAGGGCTGCTTTTAACTCTGGT-3′, GAPDH antisense 5′-GATTTTGGAGGG ATCTCGCT-3′. The amplification reaction was performed using StepOne Real-Time PCR System for 40 cycles. The data were analyzed using the 2^−ΔΔCt^ method.

Cell-Counting Kit-8 Assay {#section7-1533033819853262}
-------------------------

The proliferation of OS cells was evaluated by a Cell-Counting Kit-8 (CCK-8, TransGen, Inc., Beijing, China) assay. Osteosarcoma cells (4000/well) were seeded out in 96-well plates for 0 hour, 24 hours, and 48 hours, respectively. Then, 10 µL of CCK-8 solution was added to each well, and incubated for an additional 2 hours at 37°C. The absorbance of each wells was measured at 450 nm with a microplate reader. Three independent experiments were performed over multiple days.

Transwell Invasion Assays {#section8-1533033819853262}
-------------------------

We used the BD BioCoat BD Matrigel Invasion Chamber (BD Biosciences, Franklin Lakes, New Jersey) to analyze the cell's invasion ability according to the manufacturer's protocol. The images of OS cells were captured at 24 hours. The invaded OS cells were then fixed and stained with 0.1% crystal violet. Three randomly selected fields per membrane were photographed, and cell counting was measured by Image J software. Three independent experiments were conducted over multiple days.

Migration Assays {#section9-1533033819853262}
----------------

Osteosarcoma cells were grown to confluence in 6-well plates to a density of approximately 5 × 10^6^ cells/well. Osteosarcoma cells were denuded by dragging a rubber policeman (Fisher Scientific, Hampton, New Hampshire). Then we added fresh quiescent medium alone or containing 10% FBS into the dished and put the dishes into the incubator (37°C for 24 hours). Images were captured at 0 hours and 24 hours using an ECLIPSE TS 100 microscope (magnification, ×200; Nikon, Tokyo, Japan), and the migrated distance was measured by Image J, version 1.48 (National Center for Biotechnology Information, Bethesda, Maryland). The cells' migration rates were obtained by counting three fields per area. All independent experiments were repeated 3 times.

Protein Preparation {#section10-1533033819853262}
-------------------

Lysis buffer (2% SDS, 7 M urea, 1× Protease Inhibitor Cocktail (Roche Ltd, Basel, Switzerland) was used to lyse cells and extract proteins. The BCA protein assay was used to determine the protein concentration. Add 11µL of 1 M DTT and incubate sample at 37°C for 1 hour. 100 Mm of TEAB was added into the samples to remove urea. After adding 120 µL of 55 mM iodoacetamide, the sample was incubated for 20 minutes protected from light at room temperature. And then, the above proteins were digested by sequence-grade modified trypsin (Promega, Madison, Wisconsin).

Nano-HPLC-MS/MS Analysis {#section11-1533033819853262}
------------------------

After resuspended with 30 µL of buffer A (0.1% formic acid in water), the peptides were separated by nano-LC. And this process is analyzed by on-line electrospray tandem mass spectrometry. All experiments were performed on a Nano ACQUITY UPLC system (Waters Corporation, Milford, Massachusetts), including a Q-Exactive mass spectrometer (Thermo Fisher Scientific) equipped with an online nano-electrospray ion source. A total of 10 µL of peptide sample, with a flow of 10 µL/min for 3 minutes, was loaded onto the trap column (Thermo Scientific Acclaim PepMap C18, 100 µm × 2 cm). And then, the sample, from 3% B (B: 0.1% formic acid in ACN) to 32% B in 120 minutes, was separated on the analytical column (Acclaim PepMap C18, 75 µm × 15 cm) with a linear gradient. The column was reequilibrated for 10 minutes under initial conditions (flow rate = 300 nL/min). The electrospray voltage used was 2 kV, corresponding to the inlet of the mass spectrometer. Within data-dependent acquisition mode, the mass spectrometer was automatically switched under MS and MS/MS mode. The MS/MS resolution was maintained at 17.5K under HCD mode. MS1 mass resolution was maintained at 70K with *m/z* 300 to 1800 (dynamic exclusion time =10 seconds).

Data Analysis {#section12-1533033819853262}
-------------

PEAKS Studio version 8.5 (Bioinformatics Solutions Inc, Waterloo, Ontario, Canada) was used to process Tandem mass spectra. PEAKS DB were searched (fragment ion mass tolerance = 0.05 Da; parent ion tolerance = 7 ppm) by Swiss-Prot human database assuming the digestion enzyme Trypsin. Carbamidomethylation was setted as a fixed modification. Acetylation (Protein N-term), Oxidation (M), and Deamidation (NQ), were setted as variable modifications. Indicators for filtering proteins: 1% FDR and 1 unique peptide and protein abundance calculation were performed using analysis of analysis of variance (ANOVA). Normalization was used for on averaging the abundance of all peptides. Conditions for filtering different expressed proteins: fold change \>1.5 and contained at least 2 unique peptides with *P* \< .05.

Function Method Description {#section13-1533033819853262}
---------------------------

Hierarchical cluster analysis (HCA), as an algorithmic approach, was used to find discrete groups with varying degrees of (dis)similarity in a data set represented by a (dis)similarity matrix. This analysis is processed with pheatmap package (<https://CRAN.R-project.org/package=pheatmap>). The volcano plot is a type of scatter-plot which plots significance versus fold-change on the x- and y-axes. The volcano plot drawn by using ggplot2 package (<http://ggplot2.org>) is used to quickly identify changes in large data sets composed of replicate data. Functional annotation was processed by Blast2GO version 4. Whole protein sequence database was analyzed by BlastP using whole database and mapped, annotated with gene ontology database. Statistically altered functions of diffierent expressed proteins were calculated by Fisher exact test in BLAST2GO.^[@bibr12-1533033819853262]^ KOBAS was used for KEGG analysis^[@bibr13-1533033819853262]^ (<http://kobas.cbi.pku.edu.cn/>). Protein--protein interaction network was processed by STRING version 10^[@bibr14-1533033819853262]^ ([www.string-db.org](http://www.string-db.org)).

Statistical Analysis {#section14-1533033819853262}
--------------------

Statistical significance was analyzed using Student *t* test and ANOVA test using SPSS version l8.0 software (SPSS, Inc, Chicago, Illinois). Statistically significant difference is expressed as ∗*P* \< .05. The data were presented as the mean (standard deviation).

Results {#section15-1533033819853262}
=======

Aurora-B Promote Malignant Phenotype of OS Cells *In Vitro* {#section16-1533033819853262}
-----------------------------------------------------------

In order to investigate the biological function caused by AURKB in osteosarcoma cells, OS cells (U2-OS and 143B) were used to treat with specific Lentivirus-Vectors (up or downregulation AURKB). Transwell invasion, Wound Healing, and CCK-8 were performed to evaluate the invasion, migration, and proliferation of OS cells, respectively. Results showed that the invaded cells, migration rate and the proliferation of OS cells were significantly increased in cells upregulated AURKB than those of in negative group, and significantly reduced in cells downregulated AURKB compared to negative control group. Those results indicated inhibition AURKB repress OS cells malignant phenotype in vitro ([Figure 1](#fig1-1533033819853262){ref-type="fig"}).

![Aurora-B expression could alter OS cell migration, invasion, proliferation in vitro. A, The expression of AURKB was examined by Western blot analysis in OS cells transfected with LV-AURKB and NC-AURKB. B, The expression of AURKB mRNA was examined by qRT-PCR in OS cells transfected with LV-AURKB and NC-AURKB. GAPDH was used as the endogenous control. C, Wound healing assay(×200). Cell migration was measured 24 hours after the cell layers were scratched. \**P* \< .05, \*\**P* \< .01. D, Transwell assay. The ability of invasion was evaluated using a Matrigel invasion chamber. The invaded cells were fixed and stained with crystal violet. Six randomly selected fields were photographed and the numbers were counted (×200). Each bar represents the mean (SD) of at least three independent experiments performed in triplicate. \**P* \< .05, \*\**P* \< .01. E, The ability of proliferation were determined by CCK-8 assays. Mean (SD). Aurora-B indicates AURKB, CCK-8, Cell-Counting Kit-8; OS, osteosarcoma; qRT-PCR, quantitative reverse transcription-polymerase chain reaction.](10.1177_1533033819853262-fig1){#fig1-1533033819853262}

### Identification of DEPs {#section17-1533033819853262}

To investigate the molecular mechanisms of AURKB in the progression of Osteosarcoma, we utilized label-free quantitative proteomics technology to quantify/visualize the changes in proteins expression abundance and identify DEPs in the 2 groups (LV-AURKB and NC-AURKB) of 143B cells. We identified 101 DEPs. Among them, 76 proteins were upregulated in U (LV-AURKB) group compared to C(NC-AURKB) group and 25 were downregulated. Representative DEPs mentioned in the article identified by label-free quantitative proteomic in 143B cells are shown in [Table 1](#table1-1533033819853262){ref-type="table"}. Hierarchical cluster analysis are illustrated in [Figure 2A](#fig2-1533033819853262){ref-type="fig"}. The color depth of HCA indicates the size of the protein expression. In the vertical axis, the sample may be submitted to cluster analysis and the protein may be clustered in the horizontal direction. The volcano plot is shown in [Figure 2B](#fig2-1533033819853262){ref-type="fig"}. The red dots mean the upregulated proteins. The blue dots mean downregulated proteins. And the green dots mean those proteins without change.

###### 

Representative DEPs (\>1.50-fold/\<0.67-fold) Identified by Label-Free Quantitative Proteomic in 143B Cells.

![](10.1177_1533033819853262-table1)

  Gene Name   Accession             KEGG         STRING                 Fold Change   *P* Value
  ----------- --------------------- ------------ ---------------------- ------------- ------------
  PTK2        Q05397\|FAK1_HUMAN    hsa:5747     9606.ENSP00000341189   2.51          .024717241
  NFKB2       Q00653\|NFKB2_HUMAN   hsa:4791     9606.ENSP00000358983   2.51          .000860994
  CAT         P04040\|CATA_HUMAN    hsa:847      9606.ENSP00000241052   1.66          .027164393
  ALB         P02768\|ALBU_HUMAN    hsa:213      9606.ENSP00000295897   4.41          .002070141
  SH3PXD2B    A1X283\|SPD2B_HUMAN   hsa:285590   9606.ENSP00000309714   3.48          .014927944
  UBR5        O95071\|UBR5_HUMAN    hsa:51366    9606.ENSP00000429084   3.44          .010616956
  MMS19       Q96T76\|MMS19_HUMAN   hsa:64210    9606.ENSP00000359818   1.97          .019678863
  CCNB1       P14635\|CCNB1_HUMAN   hsa:891      9606.ENSP00000256442   1.91          .015066071
  ARF3        P61204\|ARF3_HUMAN    hsa:377      9606.ENSP00000256682   1.54          .006280584
  SRSF2       Q01130\|SRSF2_HUMAN   hsa:6427     9606.ENSP00000353089   −1.58         .006471426
  SRSF1       Q07955\|SRSF1_HUMAN   hsa:6426     9606.ENSP00000258962   −1.73         .02004472
  SRSF5       Q13243\|SRSF5_HUMAN   hsa:6430     9606.ENSP00000377892   −1.5          .014723125
  SRRM1       Q8IYB3\|SRRM1_HUMAN   hsa:10250    9606.ENSP00000326261   −1.56         .045394162
  RBM22       Q9NW64\|RBM22_HUMAN   hsa:55696    9606.ENSP00000199814   −1.63         .025822602

Abbreviation: DEPs, differentially expressed proteins.

![Profiles of DEPs in 143B cells. Left: Hierarchical cluster analysis (HCA) of the differentially expressed proteins in each group. (Red: upregulated differentially expressed proteins, Green: downregulated differentially expressed proteins). Right: The volcano plot (Red dots: upregulated proteins. blue dots: downregulated proteins. And green dot: proteins without change). DEPs indicate differentially expressed proteins.](10.1177_1533033819853262-fig2){#fig2-1533033819853262}

### Gene ontology enrichment analysis {#section18-1533033819853262}

Following GO enrichment analyses for upregulated DEPs, the GO BP (biological process) terms enriched were mainly related to actin filament-based process, actin cytoskeleton organization, localization, response to nutrient, cytoskeleton organization. The GO MF (molecular function) terms enriched were mainly associated with actin-dependent ATPase activity, microfilament motor activity, protein binding, protein complex binding, actin binding. The GO CC (Cellular Component) terms enriched were mainly associated with vesicle, extracellular exosome, extracellular vesicle, extracellular organelle, and cytoplasm. Alternatively, The GO BP terms enriched by downregulated DEPs were mainly related to RNA processing, nucleocytoplasmic transport, nuclear transport, nucleic acid metabolic process, and nuclear export. The identified proteins separated according to MF mainly include RNA binding, poly(A) RNA binding, nucleic acid binding, heterocyclic compound binding, and organic cyclic compound binding. Cellular component of the proteins was classified and large groups were found to be nuclear lumen, intracellular organelle lumen, membrane-enclosed lumen, organelle lumen, and nuclear part ([Figure 3](#fig3-1533033819853262){ref-type="fig"}).

![Representative GO enrichment analysis of (A) up and (B) downregulated DEPs. Significantly changed GO of predicted DEPs were illustrated. The left *y*-axis titled with percentage of proteins and the right *y*-axis presented number of proteins, while the *x*-axis showed GO category. DEPs indicate differentially expressed proteins; GO, gene ontology.](10.1177_1533033819853262-fig3){#fig3-1533033819853262}

### KEGG Analysis {#section19-1533033819853262}

The pathways enriched by upregulated DEPs were mainly related to regulation of actin cytoskeleton, and Fc gamma R-mediated phagocytosis. The downregulated DEPs were mainly related to spliceosome and herpes simplex infection. The top 20 pathways terms are shown in [Table 2](#table2-1533033819853262){ref-type="table"}.

###### 

Pathway Functional Enrichment Analysis for Down and Upregulated Differentially Expressed Proteins.

![](10.1177_1533033819853262-table2)

  Term                 Pathway                                           Count   *P* Value
  -------------------- ------------------------------------------------- ------- ------------
  Upregulated DEPs                                                               
   hsa04810            Regulation of actin cytoskeleton                  9       .000377604
   hsa04666            Fc gamma R-mediated phagocytosis                  5       .004729603
   hsa04370            VEGF signaling pathway                            4       .005185922
   hsa04611            Platelet activation                               5       .012559144
   hsa04072            Phospholipase D signaling pathway                 5       .017498948
   hsa04530            Tight junction                                    5       .018209861
   hsa04730            Long-term depression                              3       .023028084
   hsa04664            Fc epsilon RI signaling pathway                   3       .036051704
   hsa04670            Leukocyte transendothelial migration              4       .044611913
   hsa00350            Tyrosine metabolism                               2       .048768972
  Downregulated DEPs                                                             
   hsa03040            Spliceosome                                       5       .000006229
   hsa05168            Herpes simplex infection                          3       .013938856
   hsa03013            RNA transport                                     2       .060322556
   hsa04623            Cytosolic DNA-sensing pathway                     1       .099505944
   hsa04930            Type II diabetes mellitus                         1       .106849971
   hsa00970            Aminoacyl-tRNA biosynthesis                       1       .109588798
   hsa05130            Pathogenic Escherichia coli infection             1       .117304123
   hsa04213            Longevity regulating pathway - multiple species   1       .126744274
   hsa05221            Acute myeloid leukemia                            1       .132982584
   hsa05214            Glioma                                            1       .133426500

Abbreviation: DEPs, differentially expressed proteins; tRNA, transfer RNA; VEGF, vascular endothelial growth factor.

### Protein--protein interaction network construction {#section20-1533033819853262}

Based on data from the STRING database, the PPI network was constructed ([Figure 4](#fig4-1533033819853262){ref-type="fig"}). All nodes represent proteins and edges indicate connections between proteins. For upregulated DEPs, 10 edges were selected as hub proteins (degree ≥ 9), including ALB (degree = 17), PTK2 (degree = 9), CAT (degree = 9), AFR3 (degree = 10). For downregulated DEPs, 5 edges were selected as hub proteins (degree ≥ 5), including SRSF5 (degree = 5), SRSF1 (degree = 5), SRSF2 (degree = 5), SRRM1 (degree = 5), and RBM22 (degree = 5).

![The protein--protein interaction network of the differentially expressed proteins identified. A, upregulated DEPs (B) downregulated DEPs. Nodes represent proteins and edges indicate connections between proteins. differentially expressed proteins. DEPs indicate differentially expressed proteins.](10.1177_1533033819853262-fig4){#fig4-1533033819853262}

### Western Blot Analysis {#section21-1533033819853262}

To validate the results of bioinformatics speculation, the proteins of PTK2, AKT, p-AKT, PI3 K, p-PI3 K, and NF-κB were further confirmed by western blot. As showed in [Figure 5](#fig5-1533033819853262){ref-type="fig"}, the expression of AURKB enhanced protein expressions of PTK2, AKT, p-AKT, PI3 K, p-PI3 K, and NF-κB in 143B cells and U2-OS cells.

![Western blot analysis was carried out to determine the expression levels of PTK2, AKT, p-AKT, PI3 K, p-PI3 K, and NF-κB in transfected 143B cells (A) and U2-OS cells (B). β-actin was used as the loading control. NF-κB, nuclear factor-KappaB; OS, osteosarcoma.](10.1177_1533033819853262-fig5){#fig5-1533033819853262}

Discussion {#section22-1533033819853262}
==========

Various evidences indicated AURKB, as a oncogene, promotes malignant tumor growth and metastasis. In the present study, We confirmed that AURKB promote invasion, migration and proliferation of OS cells in vitro. Furthermore, label-free quantitative proteomics technology was used to identify the protein difference between upregulated AURKB group and negative group in 143B cells. Finally, we explored the molecular mechanism of AURKB promote malignant phenotype of osteosarcoma.

For the downregulated proteins, enriched pathways were mainly related to Spliceosome. These proteins are hub proteins in the PPI network, such as SRSF1, SRSF2, SRSF5, RBM22 and SRRM1 ([Figure 5B](#fig5-1533033819853262){ref-type="fig"}). Current research shows that alternative splicing may play a positive role in tumor genesis and development. The effects of RNA alternative splicing on tumors include long-lasting proliferative signals,^[@bibr15-1533033819853262]^ activation of invasion and metastasis,^[@bibr16-1533033819853262]^ escape of growth-suppressing genes,^[@bibr17-1533033819853262]^ resistance to apoptosis,^[@bibr18-1533033819853262]^ and so on. It is suggest that AURKB may have a certain relationship with alternative splicing. For the upregulated proteins, regulation of actin cytoskeleton pathway was noted to be enriched by several upregulated proteins, including PTK2, which were also hub proteins in the PPI network ([Figure 5A](#fig5-1533033819853262){ref-type="fig"}). It has been reported that cytoskeletal reorganization affects cell migration,^[@bibr19-1533033819853262]^ whereas invasion and metastasis of tumors are mainly dependent on cell migration.^[@bibr20-1533033819853262]^ The activation of NF-κB can be influenced by many physiopathological events including phagocytosis, pathogen invasion, cellular adhesion and chemotaxis governed by actin-based cytoskeleton.^[@bibr21-1533033819853262]^ Our previous study also confirmed that knockdown of AURKB alters osteosarcoma cell malignant phenotype via decreasing NF-κB signaling.^[@bibr9-1533033819853262]^

What fascinated us was that the major hub proteins about PTK2 in upregulated proteins. PTK2, also known as FAK, is a cytosolic non-receptor tyrosine kinase that is an important regulator of integrin-regulated signaling and plays an important regulatory role in tumor proliferation, migration, invasion, metastasis, and angiogenesis.^[@bibr22-1533033819853262]^ PTK2 is highly expressed in breast cancer, lung cancer, prostate cancer, liver cancer, pancreatic cancer, colorectal cancer and other malignant tumors.^[@bibr23-1533033819853262]^ Ren et al^[@bibr24-1533033819853262]^ reported that siRNA-based knockdown of PTK2 remarkably reduced the malignant phenotype of osteosarcoma cells. Sonody et al^[@bibr25-1533033819853262]^ conclude that PTK2 activates the PI3K/Akt/NF-KB signaling pathway with the concomitant induction of IAPs, which finally reduce apoptosis by inhibiting caspase-3 cascade. In addition, PTK2 has been shown to be significant for epithelial-tomesenchymal transition(EMT).^[@bibr26-1533033819853262]^ It has been reported that downstream signaling pathways of Src^[@bibr27-1533033819853262]^ and PI3K^[@bibr28-1533033819853262]^ are important for PTK2-mediated cell motility. Zaytsevv *et al* ^[@bibr29-1533033819853262]^ reported that inhibition of FASN attenuated the activation of MET, Akt, PTK2, and paxillin, which are known to regulate adhesion, migration, and invasion. These results collectively suggest that PTK2 over expression and phosphorylation might predict more aggressive biologic behavior in osteosarcoma and may be an independent predictor of poor prognosis. In addition, confirmed in our previous study that knockdown of AURKB inhibits OS cells malignant phenotype via modulating PI3K/Akt/NF-κB signaling pathway.^[@bibr10-1533033819853262]^ We speculate that AURKB may promote the malignant phenotype of osteosarcoma cells by activating the PTK2/PI3 K/AKt/NF-κB pathway. Finally, we confirmed by Western blot analysis that expression of PTK2, AKT, p-AKT, PI3 K, p-PI3 K, and NF-κB increased after overexpression of AURKB.

Although bioinformatics techniques of proteomics have the potential to enrich and identify disease-related potential mechanisms, there are still some limitations in this study, which lacks complete experimental validation and does not adequately demonstrate the direct relevance of all mechanisms. Further experimental studies of a larger sample size, most importantly, are still needed in the future to confirm the results. However, proteomics analysis, based on our previous studies, provides a direction for further research on the molecular mechanism of AURKB in promoting the malignant phenotype of osteosarcoma.

Conclusions {#section23-1533033819853262}
===========

In summary, our results indicated that upregulated AURKB can enhance the malignant phenotype of OS cells, and AURKB may promote the malignant phenotype of OS cells by activating the PTK2/PI3K/AKt/NF-κB pathway. Finally, we confirmed that expression of PTK2, AKT, PI3K, p-AKT, p-PI3K, and NF-κB increased after over expression of AURKB. Thus, target AURKB and PTK2/PI3K/AKt/NF-κB pathway may be a promising strategy.
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